Before joining IBM Research in Cambridge in September 2016, I completed a three-year postdoctoral training program at Massachusetts General Hospital (MGH), working closely with Harvard faculty. Now, a collaboration between MGH and IBM Research has yielded a satisfying result - our manuscript, "The MELD-Plus: A Generalizable Prediction Risk Score in Cirrhosis," was published in PLOS ONE, a peer-reviewed online science journal.Machine learning used to surpass MELD in assessing liver disease
Before joining IBM Research in Cambridge in September 2016, I completed a three-year postdoctoral training program at Massachusetts General Hospital (MGH), working closely with Harvard faculty. Now, a collaboration between MGH and IBM Research has yielded a satisfying result - our manuscript, "The MELD-Plus: A Generalizable Prediction Risk Score in Cirrhosis," was published in PLOS ONE, a peer-reviewed online science journal.
Machine Learning, Artificial Intelligence, and Deep Learning News around the world. We publish the latest developments and advances in these fields.
Sunday, October 29, 2017
Machine learning used to surpass MELD in assessing liver disease
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment